Vepdegestrant (ARV-471) 是一种具有选择性和高效性的雌激素受体(ER,ESR1)PROTAC 降解剂,对 ER 蛋白具有强效降解能力。Vepdegestrant 通过直接降解 ER 蛋白而非单纯拮抗其活性,有效抑制 ER 信号通路,在 ER 阳性(ER⁺)乳腺癌中表现出显著的抗肿瘤活性,DC50 值约为 2 nM,尤其对 ESR1 突变型肿瘤同样具有良好效果。
FT3967385 is a newly developed compound that functions as a USP30 inhibitor, emulating the genetic deficiency of USP30. This inhibition serves as a catalyst for the amplification of mitochondrial ubiquitylation through the PINK1-PARKIN pathway.
FT385 is a novel USP30 inhibitor, recapitulating genetic loss of USP30 and setting the trigger for PINK1-PARKIN amplification of mitochondrial ubiquitylation.